Abstract

1,4-Dihydropyridines and 4H-pyran derivatives are common and important structures in various pharmaceutical compounds. Dihydropyridines are well-known moieties in compounds that have analgesic, fungicidal, and antibacterial activities and 4H-pyran structures are populous in compounds with antibacterial and anti-cancer potential; exploiting the biological activities of both 1,4-dihydropyridines and 4H-pyran moieties through the exploration of hybrid compounds featuring combinations of these two heterocyclic functionalities is an interesting avenue of research. In this research, we developed novel 1,4-dihydropyridines and 4H-pyran hybrid compounds generated under organocatalytic conditions and evaluated their cytotoxic activity toward KB and HepG2 cancer cell lines.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call